Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
405-04-009 ISMRM Abstract

Predictive Value of MR Cytometry at Different Diffusion Times for pCR in Breast Cancer After Neoadjuvant Chemotherapy

Primary: Diffusion - DWI/DTI/DKI
Secondary: Body - Breast
405-04-009 · From Diffusion Characteristics Toward Clinical Impact · Tuesday, 12 May, 4:00 PM–5:50 PM · Ballroom West
Keywords: Breast cancer Pathological complete response Neoadjuvant Chemotherapy Temporal diffusion spectroscopy RECIST1.1
Accepted
JIE DING 1, Diwei Shi2, Chao You3, Junzhong Xu4, Caixia Fu5, Xiuzheng Yue6, Hua Guo7, Yajia Gu3
1Medical Imaging Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China
2Research Institute of Tsinghua University in Shenzhen, China
3Fudan University Shanghai Cancer Center, Shanghai, China
4Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, United States of America
5Application Development, Siemens Shenzhen Magnetic Resonance Ltd., Shenzhen, P.R. China, China
6Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
7Tsinghua University, Beijing, China
Presenting Author: JIE DING

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. LI W, PARTRIDGE S C, NEWITT D C, et al. Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge[J/OL]. Radiology: Imaging Cancer, 2024, 6(1): e230033. DOI:10.1148/rycan.230033. [doi]
2. BA R, WANG X, ZHANG Z, et al. Diffusion-time dependent diffusion MRI: effect of diffusion-time on microstructural mapping and prediction of prognostic features in breast cancer[J/OL]. European Radiology, 2023, 33(9): 6226-6237.DOI:10.1007/s00330-023-09623-y. [doi]
3. WANG X, BA R, HUANG Y, et al. Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer[J/OL]. Radiology, 2024, 313(1): e240288. DOI:10.1148/radiol.240288. [doi]
4. JIANG X, LI H, DEVAN S P, et al. MR cell size imaging with temporal diffusion spectroscopy[J/OL]. Magnetic Resonance Imaging, 2021, 77: 109-123. DOI:10.1016/j.mri.2020.12.010. [doi]
5. LEVEE A, WONG M, FLORES S, et al. Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis[J/OL]. The Oncologist, 2024, 29(7): 566-574. DOI:10.1093/oncolo/oyae064. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/405-04-009